Stone Run Capital’s Merck MRK Stock Holding History

Stone Run Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,910	Closed	-$217K	–	69
2024 Q3	$217K	Buy	1,910 +6	+0.3%	+$713	0.08%	68
2024 Q2	$236K	Buy	1,904 +5	+0.3%	+$644	0.09%	62
2024 Q1	$251K	Buy	1,899 +6	+0.3%	+$740	0.1%	62
2023 Q4	$206K	Sell	1,893 -255	-12%	-$26.5K	0.09%	62
2023 Q3	$221K	Hold	2,148	–	–	0.11%	56
2023 Q2	$248K	Hold	2,148	–	–	0.11%	55
2023 Q1	$229K	Hold	2,148	–	–	0.11%	57
2022 Q4	$238K	Buy	+2,148	New	+$220K	0.12%	55
2021 Q2	–	Sell	-6,257	Closed	-$461K	–	66
2021 Q1	$461K	Hold	6,257	–	–	0.18%	53
2020 Q4	$489K	Hold	6,257	–	–	0.19%	49
2020 Q3	$495K	Hold	6,257	–	–	0.23%	46
2020 Q2	$462K	Hold	6,257	–	–	0.23%	46
2020 Q1	$460K	Hold	6,257	–	–	0.26%	48
2019 Q4	$543K	Buy	6,257 +16	+0.3%	+$1.31K	0.24%	45
2019 Q3	$501K	Hold	6,241	–	–	0.24%	45
2019 Q2	$499K	Hold	6,241	–	–	0.23%	46
2019 Q1	$495K	Buy	6,241 +6	+0.1%	+$449	0.24%	47
2018 Q4	$454K	Buy	6,235 +6	+0.1%	+$424	0.28%	45
2018 Q3	$422K	Buy	6,229 +5	+0.1%	+$319	0.19%	55
2018 Q2	$360K	Hold	6,224	–	–	0.19%	56
2018 Q1	$324K	Hold	6,224	–	–	0.17%	60
2017 Q4	$334K	Hold	6,224	–	–	0.17%	61
2017 Q3	$380K	Hold	6,224	–	–	0.2%	61
2017 Q2	$380K	Hold	6,224	–	–	0.21%	59
2017 Q1	$377K	Hold	6,224	–	–	0.23%	57
2016 Q4	$349K	Hold	6,224	–	–	0.23%	56
2016 Q3	$371K	Hold	6,224	–	–	0.23%	57
2016 Q2	$342K	Hold	6,224	–	–	0.22%	56
2016 Q1	$315K	Hold	6,224	–	–	0.2%	60
2015 Q4	$314K	Hold	6,224	–	–	0.22%	57
2015 Q3	$293K	Sell	6,224 -314	-5%	-$16.7K	0.23%	59
2015 Q2	$355K	Hold	6,538	–	–	0.23%	65
2015 Q1	$358K	Hold	6,538	–	–	0.23%	70
2014 Q4	$365K	Hold	6,538	–	–	0.25%	73
2014 Q3	$370K	Hold	6,538	–	–	0.26%	70
2014 Q2	$361K	Hold	6,538	–	–	0.24%	71
2014 Q1	$354K	Sell	6,538 -53	-0.8%	-$2.74K	0.26%	66
2013 Q4	$315K	Buy	6,591 +195	+3%	+$8.91K	0.22%	66
2013 Q3	$291K	Buy	6,396 +404	+7%	+$18.4K	0.24%	64
2013 Q2	$269K	Buy	+5,992	New	+$268K	0.26%	63

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stone Run Capital's MRK Position: Q4 2024 in Review

Stone Run Capital sold out of Merck (MRK) in Q4 2024, closing a stake of 1,910 shares — an estimated $217K sold.

Stone Run Capital first reported a position in MRK in Q2 2013 and held it in 40 quarters. The position peaked at $543K in Q4 2019. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

Stone Run Capital reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
Stone Run Capital sold 1,910 Merck shares in Q4 2024, an estimated $217K.
Stone Run Capital first reported a position in Merck in Q2 2013 and held it in 40 quarters.
Stone Run Capital's Merck position peaked at $543K in Q4 2019.
3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Stone Run Capital's 13F filing for Q4 2024, filed 14 Feb 2025.